Mogling Bio Inc.
PrivateLast Round
Seed
Nov 6, 2023
Company Overview
Mogling Bio Inc. is a biopharmaceutical company that develops pharmacological therapies to rejuvenate hematopoietic stem cells and restore immune system function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mogling Bio Inc. Comparables
Compare Mogling Bio Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmuneAGE Bio | 85% | |
| Turn Biotechnologies | 68% | |
| Retro Biosciences | 66% | |
Mogling Bio Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 6, 2023 | ||||
| Seed | Oct 26, 2022 |
Mogling Bio Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kizoo Technology Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2023
Seed round led by Kizoo Technology Capital.
Mogling Bio Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mogling Bio Inc.'s valuation, stock price, and market status.